Free tool
Oncology stocks
We cover 5 companies grouped under the Oncology theme. The median market value in the group is $21.42B. Across the group, the median move over the past trading day is +1.97%. Price change over the past year runs from +13.0% to +48.7% across the middle 80 percent of the group, with a median of +21.9%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| ONC | BeOne Medicines AG | $42.58B | Large cap | +21.95% |
| BNTX | BioNTech SE | $28.65B | Large cap | +8.55% |
| GMAB | Genmab A/S | $21.42B | Large cap | +41.34% |
| 0J9P.L | Incyte Corporation | $21.10B | Large cap | +53.55% |
| 0M2N.L | Orion Oyj | $11.16B | Large cap | +19.68% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.